Donata Grimm

Papers

Total Citations

H-Index

About

Donata Grimm is a distinguished gynecologic oncologist whose research centers on the surgical management and clinical outcomes of borderline ovarian tumors (BOT) and ovarian malignancies. Her major contribution lies in systematically evaluating perioperative morbidity in patients with primary BOT, demonstrating that while surgery remains the cornerstone of treatment, careful consideration of surgical radicality is essential to minimize complications in patients with excellent long-term prognosis. Her seminal 2013 paper on this topic, which has garnered 24 citations, provides critical evidence guiding treatment strategies that balance oncologic safety with quality of life. Grimm’s work has helped refine clinical decision-making, emphasizing that in BOT—where survival rates are exceptionally high—the primary challenge is reducing surgical morbidity rather than maximizing radicality. Her research continues to influence guidelines for conservative surgical approaches, sparing patients unnecessary aggressive procedures. Through her focused investigations, Grimm has established herself as a key voice in optimizing perioperative care for women with borderline ovarian tumors, ensuring that treatment strategies prioritize both oncologic efficacy and patient well-being.